Carbocromen was marketed for use in Germany as a vasodilator, however, it has been discontinued due to the risk of arrhythmia development L5635.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Patent Blue | The therapeutic efficacy of Carbocromen can be decreased when used in combination with Patent Blue. |
| Dexmethylphenidate | The serum concentration of the active metabolites of Carbocromen can be increased when Carbocromen is used in combination with Dexmethylphenidate. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Carbocromen. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Carbocromen. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Carbocromen. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Carbocromen. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Carbocromen. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Carbocromen. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Carbocromen. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Carbocromen. |
| Gliquidone | The therapeutic efficacy of Gliquidone can be increased when used in combination with Carbocromen. |
| Glisoxepide | The therapeutic efficacy of Glisoxepide can be increased when used in combination with Carbocromen. |
| Glibornuride | The therapeutic efficacy of Glibornuride can be increased when used in combination with Carbocromen. |
| Carbutamide | The therapeutic efficacy of Carbutamide can be increased when used in combination with Carbocromen. |
| Metahexamide | The therapeutic efficacy of Metahexamide can be increased when used in combination with Carbocromen. |
| Isosorbide mononitrate | Carbocromen may increase the vasodilatory activities of Isosorbide mononitrate. |
| Lepirudin | The risk or severity of bleeding can be increased when Carbocromen is combined with Lepirudin. |
| Doxycycline | The therapeutic efficacy of Carbocromen can be increased when used in combination with Doxycycline. |
| Diazoxide | The serum concentration of Carbocromen can be increased when it is combined with Diazoxide. |
| Iloprost | Iloprost may increase the hypotensive activities of Carbocromen. |